|
|
||||||||
|
|
|||||||||
|
|
Cardiovascular: Clinical ScienceClinical Science Posters |
1 Vanderbilt Hosp., Nashville, Tennessee; 2 Rambam Healthcare, Haifa, Israel
886
Objectives: Determine the impact of integrated MPS and CTA on management (mgt) of symptomatic patients (pts) with intermediate likelihood of CAD.
Methods: 71 pts had rest/stress MPS and CTA with an integrated system (Ventri/VCT, GE Healthcare) in 2 hospitals. The impact on mgt was reviewed with this algorithm: the 2nd noninvasive test is performed if the 1st is equivocal and catheterization (cath) is performed if a noninvasive test is definitely abnormal. Potentially avoided invasive cath procedures were determined with this hypothesis: cath would be done when the 1st test is equivocal and the 2nd test was unavailable. The most helpful test was identified by a cardiologist panel with knowledge of clinical data.
Results: 6 and 7 pts would be selected for cath if MPS or CTA was the 1st study respectively. A 2nd test would be performed in 28% and 39% pts if MPS or CTA was the 1st study respectively. Cath would be avoided in 22% and 32% pts if MPS or CTA was the 1st study respectively. If MPS was done 1st, an added CTA to a normal MPS guided towards intensive medical therapy in 32% pts. If CTA was done 1st, no other test was necessary in 60% pts (71% with atypical, 25% with typical symptoms). Either MPS or CTA would have sufficed in 47% pts with atypical symptoms but the combination of both was useful in 75% pts with typical symptoms.
Conclusions: MPS and CTA have complementary roles. Regardless whether MPS or CTA was the 1st study, the same pts were selected for cath except one. Addition of a 2nd noninvasive test avoids invasive procedures in > 20% pts. While in pts with atypical symptoms, CTA 1st may be the best choice, combined MPS/CTA may play a role in mgt decisions in pts with typical symptoms.
| ||||||||||||||||||||||||||||||||||||||